A

AUSL di Bologna | Ospedale Bellaria - IRCCS Istituto delle Scienze Neurologiche di Bologna - Neurology Department

Research site
(Unclaimed)
Location
3 Via Altura, Bologna, Bologna, Italy
Site insights

Top conditions

Cerebral Infarction (1 trial)

Ischemia (1 trial)

Ischemic Stroke (1 trial)

Heart Failure (1 trial)

Transient Ischemic Attack (1 trial)

Top treatments

Androgen
Finerenone
Darolutamide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP)

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means that in men who had p...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Researchers are looking for a better way to prevent an ischemic stroke which occurs when a blood clot travelled to the brain in people who within the...

Enrolling
High-risk Transient Ischemic Attack
Acute Non-cardioembolic Ischemic Stroke
Drug: Placebo
Drug: Asundexian (BAY2433334)

The purpose of this study is to evaluate the effect of finerenone compared to placebo (a tablet without active substance) in the reduction of cardiov...

Active, not recruiting
Heart Failure
Other: Placebo
Drug: Finerenone (BAY94-8862)

Trial sponsors

Bayer logo

Bayer (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems